TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biokjemi Norge AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
18,740
|
15,598
|
13,384 |
| Financial expenses |
148
|
192
|
151 |
| Earnings before taxes |
1,237
|
235
|
-1,245 |
| Total assets |
7,853
|
8,711
|
8,947 |
| Current assets |
6,056
|
6,795
|
6,788 |
| Current liabilities |
3,430
|
5,216
|
5,474 |
| Equity capital |
4,423
|
3,495
|
3,473 |
| - share capital |
63
|
66
|
71 |
| Employees (average) |
6
|
6
|
6 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
56.3%
|
40.1%
|
38.8% |
| Turnover per employee |
3,123
|
2,600
|
2,231 |
| Profit as a percentage of turnover |
6.6%
|
1.5%
|
-9.3% |
| Return on assets (ROA) |
17.6%
|
4.9%
|
-12.2% |
| Current ratio |
176.6%
|
130.3%
|
124.0% |
| Return on equity (ROE) |
28.0%
|
6.7%
|
-35.8% |
| Change turnover |
3,925
|
3,037
|
-4,236 |
| Change turnover % |
26%
|
24%
|
-24% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.